Showing 2171-2180 of 3812 results for "".
Lasers In Practice: Reducing the Appearance of Stretch Marks with Multiple Laser Technologies
https://practicaldermatology.com/topics/general-topics/lasers-in-practice-reducing-the-appearance-of-stretch-marks-with-multiple-laser-technologies/21769/Traditionally difficult to treat, stretch marks may respond to a combination of modalities provided in sync.Keep Your Dermatology Practice HIPAA Compliant With These 5 Photo Tips
https://practicaldermatology.com/topics/practice-management/keep-your-dermatology-practice-hipaa-compliant-with-these-5-photo-tips/20684/Recommendations for managing patient photos while preserving privacy.Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-corticosteroids-and-topical-calcineurin-inhibitors-atopic-dermatitis/29118/Analysis of a 2024 study by Gether et al., in which the authors compared the effectiveness of topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) in adults with atopic dermatitis (AD).Maskne and Beyond: Effects on the Skin and Implications of Occlusion and Friction
https://practicaldermatology.com/topics/acne-rosacea/maskne-and-beyond-effects-on-the-skin-and-implications-of-occlusion-and-friction/23517/An update on the skin effects of mask-wearing.Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis Patients
https://practicaldermatology.com/topics/research-update/monoclonal-antibodies-restoring-healthy-skin-microbiome-atopic-dermatitis-patients/24566/Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis PatientsA Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.Dermatology and the ICD-10 Code Conundrum
https://practicaldermatology.com/topics/practice-management/dermatology-and-the-icd-10-code-conundrum/21372/EHRs equipped for ICD-10 can make the impending transition smooth for any practice.GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muStaphylococcus aureus Colonization
https://practicaldermatology.com/issues/september-2025/staphylococcus-aureus-colonization/37626/In a recent review article, Piewngam and Otto examined the epidemiology, mechanisms, and clinical implications of Staphylococcus aureus (S. aureus) colonization, while evaluating both current and emerging strategies for decolonization.Currents: Targeted Opportunities
https://practicaldermatology.com/topics/practice-management/currents-targeted-opportunities/23097/Reach your goals in dermatology practice.